Jeffrey Mandel Sells 9,000 Shares of Covalon Technologies Ltd (TSE:COV) Stock

Covalon Technologies Ltd (TSE:COV) Director Jeffrey Mandel sold 9,000 shares of the firm’s stock in a transaction dated Thursday, September 7th. The shares were sold at an average price of C$2.99, for a total value of C$26,910.00.

Jeffrey Mandel also recently made the following trade(s):

  • On Wednesday, September 6th, Jeffrey Mandel sold 1,000 shares of Covalon Technologies stock. The stock was sold at an average price of C$2.99, for a total value of C$2,990.00.
TRADEMARK VIOLATION WARNING: “Jeffrey Mandel Sells 9,000 Shares of Covalon Technologies Ltd (TSE:COV) Stock” was first posted by TrueBlueTribune and is the sole property of of TrueBlueTribune. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright legislation. The correct version of this news story can be read at https://www.truebluetribune.com/2017/09/17/jeffrey-mandel-sells-9000-shares-of-covalon-technologies-ltd-cov-stock.html.

About Covalon Technologies

Covidien Public Limited Company is a healthcare products company. The Company is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. The Company’s brands include Kendall, Nellcor, Puritan Bennett and Valleylab, among others. It has a presence in more than 70 countries, with products sold in over 150 countries.

Receive News & Ratings for Covalon Technologies Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covalon Technologies Ltd and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply